Table 3.
Impact of COVID-19 pandemic on time to treatment initiation among cancer patients.
| Variable | Pre-COVID 19 | COVID-19 | P value | |
|---|---|---|---|---|
| (N=228) | (N=188) | |||
| Time from initial visit to treatment initiation | 33.5 (31.5) | 24.9 (17.4) | 0.001 | |
| (days, mean +/− SD) | ||||
| race | White | 31.6 (28.0) | 25.1 (16.8) | 0.012 |
| Black | 43.5 (45.1) | 26.1 (22.8) | 0.062 | |
| Asian | 30.0 (18.5) | 22.0 (3.5) | 0.803 | |
| insurance | Private | 31.1 (30.3) | 23.9 (15.8) | 0.050 |
| Medicare | 33.4 (30.7) | 26.9 (17.6) | 0.107 | |
| Medicaid | 44.0 (42.1) | 26.1 (23.5) | 0.102 | |
| Uninsured | 45.3 (28.4) | 20.0 (14.4) | 0.238 | |
| Number of comorbidities | 0 | 31.5 (21.7) | 24.5 (18.8) | 0.007 |
| 1 | 33.0 (38.3) | 25.3 (15.1) | 0.168 | |
| 2 | 47.9 (64.1) | 24.4 (12.9) | 0.200 | |
| >2 | 46.6 (26.8) | 35.3 (9.4) | 0.511 | |
| BMI | <25 | 32.5 (41.3) | 28.2 (20.0) | 0.554 |
| 25–29.9 | 29.6 (22.1) | 30.5 (22.6) | 0.846 | |
| 30–39.9 | 28.5 (16.8) | 20.6 (13.1) | 0.004 | |
| ≥4# | 49.0 (45.0) | 22.6 (12.4) | 0.001 | |
| Smoking status | Non-smoker | 33.5 (31.5) | 24.4 (16.5) | 0.001 |
| Current smoker | 33.4 (32.1) | 26.9 (21.0) | 0.346 | |
| Service location | Fellow clinic | 39.3 (32.8) | 25.8 (21.6) | 0.120 |
| Faculty clinics | 32.9 (31.4) | 26.7 (25.9) | 0.002 | |
| Disease site | Uterus | 36.2 (35.4) | 23.6 (14.3) | <0.001 |
| Ovary, fallopian tube, primary peritoneal | 24.8 (17.9) | 24.8 (20.0) | 1.0 | |
| Cervix | ||||
| Vulva | 44.8 (32.6) | 33.3 (24.8) | 0.204 | |
| Vagina | 32.0 (23.3) | 21.1 (10.9) | 0.222 | |
| 10.3 (8.5) | 34.3 (15.3) | 0.034 | ||